These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 811146)

  • 1. [A new vaccinating antigenic fraction obtained from "Vibrio cholerae" I.--Isolation and characterization of the new fraction (author's transl)].
    Dodin A; Wiart J
    Ann Microbiol (Paris); 1975 Jan; 126(1):39-44. PubMed ID: 811146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new vaccinating antigenic fraction obtained from "Vibrio cholerae" II. Biological properties of the Ch1+2 fraction compared with the bacterial vaccine (author's transl)].
    Dobin A; Wiart J
    Ann Microbiol (Paris); 1975 Jan; 126(1):45-56. PubMed ID: 811147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Animal study on radioactive antigenic fractions isolated from V.cholerae. I. The Ch 1 + 2 fraction].
    Dodin A; Plawecki M
    Bull Soc Pathol Exot Filiales; 1978; 71(1):22-33. PubMed ID: 719845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
    María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
    Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protection.
    Sinha VB; Jacob A; Srivastava R; Kaper JB; Srivastava BS
    Vaccine; 1993; 11(3):372-5. PubMed ID: 8447164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The population composition of cultures of Vibrio cholerae strain 569 B Pakistan in relation to the manufacture of a cholera vaccine (choleragen-anatoxin+O-antigen)].
    Lobanov VV; Nechetskaia RM; Adamova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):73-6. PubMed ID: 2461623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Vibrio cholerae toxoid on the levels of antibodies of the IgG, IgA and IgM classes in rabbits].
    Aleksandrowicz J; Kudelski Z
    Med Dosw Mikrobiol; 1986; 38(1):15-22. PubMed ID: 3713366
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibrio cholerae El Tor and its role in protection.
    Jacob A; Sinha VB; Sahib MK; Srivastava R; Kaper JB; Srivastava BS
    Vaccine; 1993; 11(3):376-82. PubMed ID: 8447165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of specific O-antigen in atypical cultures of Vibrio cholerae with the aid of immunochemical methods of study].
    Lavrovskaia VM; Taraniuk ZE; Pinchuk LM; Al'tman RSh
    Lab Delo; 1975; (12):735-8. PubMed ID: 57271
    [No Abstract]   [Full Text] [Related]  

  • 11. [Developmental aspects of organism immunoreactivity in vaccination against cholera (author's transl)].
    Gorkova AV; Kuznĕcov OR; Naumsina MS; Adamov AK
    Cesk Epidemiol Mikrobiol Imunol; 1975 May; 24(3):136-42. PubMed ID: 126811
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antigens common to cholera vibrio and to man].
    Belova TN; Efimov DD
    Biull Eksp Biol Med; 1972 Sep; 73(9):62-4. PubMed ID: 4629385
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cellular response in the mouse to two antigenic extracts from "Vibrio cholerae" (author's transl)].
    Goichot J; Dodin A
    Ann Microbiol (Paris); 1978; 129B(2):195-202. PubMed ID: 568906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and biological evaluation of toxoids obtained from Vibrio cholerae].
    Kudelski Z; Zakrzewska A
    Med Dosw Mikrobiol; 1986; 38(4):205-14. PubMed ID: 3561095
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological studies on the ammonium sulphate fractions of Vibrio cholerae cell lysate.
    Guhathakurta B; Sasmal D; Datta GC; Datta A
    Indian J Exp Biol; 1978 May; 16(5):569-72. PubMed ID: 369995
    [No Abstract]   [Full Text] [Related]  

  • 16. Subunit structure of cholera toxin.
    Lönnroth I; Holmgren J
    J Gen Microbiol; 1973 Jun; 76(2):417-27. PubMed ID: 4198716
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen).
    Finkelstein RA; Boesman M; Neoh SH; LaRue MK; Delaney R
    J Immunol; 1974 Jul; 113(1):145-50. PubMed ID: 4208916
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of vaccines against cholera and diarrhoea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting.
    Bull World Health Organ; 1990; 68(3):303-12. PubMed ID: 2203550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vaccine against cholera prepared from Vibrio cholerae antigen(s).
    Chaicumpa W; Chaisri U; Tapchaisri P; Chongsa-Nguan M; Pongponratn E
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):142-8. PubMed ID: 3313733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.